73 filings
6-K
ICCM
IceCure Medical Ltd.
7 May 24
Report of Foreign Private Issuer
8:40am
6-K
ICCM
IceCure Medical Ltd.
15 Apr 24
Report of Foreign Private Issuer
9:28am
6-K
ICCM
IceCure Medical Ltd.
15 Apr 24
IceCure Medical Reports Final ICE3 Breast Cancer
8:40am
6-K
ICCM
IceCure Medical Ltd.
3 Apr 24
Report of Foreign Private Issuer
8:40am
6-K
ICCM
IceCure Medical Ltd.
2 Apr 24
IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes
8:40am
6-K
i66p wn5qqa3hq
19 Mar 24
Report of Foreign Private Issuer
8:35am
6-K
dcsefiqwbmt
12 Mar 24
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes
8:45am
6-K
rpg70 s8krtaefmkx
4 Mar 24
Report of Foreign Private Issuer
8:35am
6-K
ppzuhic4e
26 Feb 24
Study Using IceCure’s ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
8:15am
6-K
br2uh04yvjd
30 Jan 24
IceCure to submit full 5-year dataset from entire ICE3 study population to the FDA this spring, ahead of previous expectation
8:15am
6-K
935lnub 8gpm
12 Jan 24
Report of Foreign Private Issuer
4:18pm
6-K
tzesbp
12 Jan 24
Report of Foreign Private Issuer
4:10pm
6-K
ad64 kvper
10 Jan 24
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase in Sales in Preliminary Unaudited 2023 Results
8:15am
6-K
uc8pc52xbj5f9mex
13 Dec 23
Report of Foreign Private Issuer
8:05am
6-K
26jkdddb mshn5p
29 Nov 23
Report of Foreign Private Issuer
8:11am
6-K
t0fhj2nt2tigdfygdhu
15 Nov 23
IceCure Medical Files Appeal with U.S. FDA Requesting a Review of its De Novo Classification for ProSense® in Early-Stage Breast Cancer
8:06am
6-K
pljhd thmh
3 Nov 23
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
4:26pm
6-K
j4xc7n 6vpk
5 Oct 23
Report of Foreign Private Issuer
8:11am
6-K
kxj7gbz2lmverfe
2 Oct 23
Report of Foreign Private Issuer
8:00am
6-K
w6s5x540ts
20 Sep 23
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
7:15am